Article de revue
HPV vaccination: for women of all ages?
The discovery of human papillomavirus (HPV) DNA in cervical cancer by Harald zur Hausen sparked 30 years of research that established that persistent cervical infection by certain HPV genotypes causes cervical cancer. This research has led to revolutionary technical advances for the prevention of cervical cancer: prophylactic HPV vaccination and sensitive molecular HPV testing for screening. These promising technologies can be used to complement or enhance established cervical cancer prevention programmes, and to provide robust solutions in low-resource settings without screening programmes.
Auteurs
Langues
- Anglais
Année de publication
2014
Journal
Vaccine
Volume
9961
Type
Article de revue
Catégories
- Vaccins et dispositifs d'administration
Maladies
- Papillomavirus humain
Mots-clés
- Introduction de nouveaux vaccins
